Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2530570123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Brynn E LeMasters und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Islet Amyloid Polypeptide, Amyloid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, HHS | NIH (NIH).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Some mammals develop amyloid plaques and type 2 diabetes, much like humans, depending on the sequence of their islet amyloid polypeptide (IAPP). In humans, IAPP forms a toxic oligomer with a parallel β-sheet across residues 23 FGAIL 28 S. Using two-dimensional infrared spectroscopy, we monitor the structure of IAPP from seven different mammals, five of which are from species that can develop type 2 diabetes (ferret, raccoon, cat, baboon, and human) and three from those that do not (hamster, rat, and pig). G24 is isotope labeled to monitor for the presence of the oligomeric β-sheet previously found in human IAPP. For the species that develop type 2 diabetes, their IAPP is cytotoxic, and a β-sheet at G24 is observed during the lag phase prior to fibril formation. In contrast, the species that do not develop type 2 diabetes have nontoxic IAPP, and their IAPP does not form this β-sheet structure. Pig IAPP forms oligomers, but with a different structure that is nontoxic. Thus, an oligomer with a parallel β-sheet at G24 that resembles that of the known human IAPP oligomer correlates with cytotoxicity and propensity for type 2 diabetes. These results indicate that the sequence within the 20 to 29 region of human islet amyloid polypeptide (hIAPP), long known to correlate with type 2 diabetes in mammals, determines the structure and toxicity of an oligomer, supporting the oligomer hypothesis for type 2 diabetes and providing an explanation other than plaque formation for why some mammals develop insulin deficiency in late-stage type 2 diabetes, and others do not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706.
- Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
ORCID-Profile: Brynn E LeMasters, Justin P Lomont
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- HHS | NIH (NIH)
Zitieren
APA
LeMasters, B. E., Fields, C. R., Lomont, J. P., Chalyavi, F., Rich, K. L., Stapleton, D. S., Dicke, S. S., Keller, M. P., Attie, A. D., & Zanni, M. T. (2026). Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2530570123
Vancouver
LeMasters BE, Fields CR, Lomont JP, Chalyavi F, Rich KL, Stapleton DS, et al. Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2530570123
BibTeX
@article{LeMasters2026,
author = {LeMasters, Brynn E and Fields, Caitlyn R and Lomont, Justin P and Chalyavi, Farzaneh and Rich, Kacie L and Stapleton, Donald S and Dicke, Sidney S and Keller, Mark P and Attie, Alan D and Zanni, Martin T},
title = {Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2530570123}
}
EUVIMED